Table II.
Analysis of efficacy.
| Variable | FOLFOX, n=87 (%) | EOX, n=26 (%) | t/χ2 | P-value |
|---|---|---|---|---|
| Surgical procedure | ||||
| Radical operation, R0 | 69 (79.3) | 22 (84.6) | 0.359 | 0.549 |
| Palliative operation, R1 | 18 (20.7) | 4 (15.4) | ||
| Pathological T classification | 1.382 | 0.047 | ||
| pT0 | 5 (5.7) | 3 (11.5) | ||
| pT1 | 8 (9.2) | 4 (15.4) | ||
| pT2 | 8 (9.2) | 3 (11.5) | ||
| pT3/pT4 | 66 (75.9) | 16 (61.5) | ||
| Pathological N classification | 20.983 | 0.000 | ||
| N− | 28 (32.2) | 11 (42.3) | ||
| N+ | 59 (67.8) | 15 (57.7) | ||
| TRG | 6.641 | 0.156 | ||
| 0 | 10 (11.5) | 5 (19.2) | ||
| 1 | 28 (32.2) | 4 (15.4) | ||
| 2 | 32 (36.8) | 7 (26.9) | ||
| 3 | 13 (14.9) | 7 (26.9) | ||
| 4 | 4 (4.6) | 3 (11.5) | ||
| Pathological response | 3.941 | 0.047 | ||
| TRG 0–2 | 70 (80.5) | 16 (61.5) | ||
| TRG 3,4 | 17 (19.5) | 10 (38.5) | ||
TRG, tumour regression grade.